The overall survival analysis using the Kaplan–Meier method revealed that the prognosis of lung cancer patients with high or moderate NDRG2 expression was significantly better than those with no or weak NDRG2 expression, and moderate expression was better than high expression (see Fig. 1b; P = 0.001). Here, NDRG2 is linked to lung cancer.